Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 217, Issue 2, Pages 213-222
Publisher
Oxford University Press (OUP)
Online
2017-11-06
DOI
10.1093/infdis/jix582
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors
- (2017) Petra J. Woestenberg et al. JOURNAL OF INFECTION
- Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis
- (2016) K Cuschieri et al. BRITISH JOURNAL OF CANCER
- Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study
- (2016) David Mesher et al. BMJ Open
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda
- (2016) Edward Kumakech et al. PLoS One
- Comparison of STI-related consultations among ethnic groups in the Netherlands: an epidemiologic study using electronic records from general practices
- (2015) Petra J. Woestenberg et al. BMC Family Practice
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study
- (2015) Madelief Mollers et al. VACCINE
- Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study
- (2014) Patrícia S de Araujo-Souza et al. BMC INFECTIOUS DISEASES
- Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
- (2014) K G J Pollock et al. BRITISH JOURNAL OF CANCER
- Post HocAnalysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA
- (2014) Frank Struyf et al. Clinical and Vaccine Immunology
- Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data
- (2014) Megan A. Smith et al. JOURNAL OF INFECTIOUS DISEASES
- Patterns of Human Papillomavirus DNA and Antibody Positivity in Young Males and Females, Suggesting a Site-Specific Natural Course of Infection
- (2014) Henrike J. Vriend et al. PLoS One
- Decreased Management of Genital Warts in Young Women in Australian General Practice Post Introduction of National HPV Vaccination Program: Results from a Nationally Representative Cross-Sectional General Practice Study
- (2014) Christopher Harrison et al. PLoS One
- Epidemiologic Approaches to Evaluating the Potential for Human Papillomavirus Type Replacement Postvaccination
- (2013) J. E. Tota et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- A Human Papilloma Virus Testing Algorithm Comprising a Combination of the L1 Broad-Spectrum SPF10 PCR Assay and a Novel E6 High-Risk Multiplex Type-Specific Genotyping PCR Assay
- (2013) D. van Alewijk et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Colonisation endpoints in Streptococcus pneumoniae vaccine trials
- (2013) Kari Auranen et al. VACCINE
- Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: A transmission-dynamic modeling study
- (2013) Marc Brisson et al. VACCINE
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Seroprevalence of seven high-risk HPV types in The Netherlands
- (2012) Mirte Scherpenisse et al. VACCINE
- Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence
- (2011) Johannes A. Bogaards et al. EPIDEMIOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Type-Specific Human Papillomavirus Infections Among Young Heterosexual Male and Female STI Clinic Attendees
- (2011) Henrike J. Vriend et al. SEXUALLY TRANSMITTED DISEASES
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- Marginal and Mixed-Effects Models in the Analysis of Human Papillomavirus Natural History Data
- (2010) X. Xue et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
- (2010) Basil Donovan et al. LANCET INFECTIOUS DISEASES
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- Determinants for HPV vaccine uptake in the Netherlands: A multilevel study
- (2009) Marc Rondy et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started